Valeo Pharma Inc. Valeo Pharma Inc.

Valeo Pharma Inc.

VPHIF

Rank in Stocks #34471
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to... Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/LAMA/ICS) and Atectura Breezhaler (a dual-combination LABA/ICS). The company also offers Redesca, crucial for preventing and treating deep vein thrombosis and pulmonary embolism. For neurological conditions, Valeo markets Onstryv, an add-on treatment for Idiopathic Parkinson's Disease in patients on stable Levodopa, and Benztropine, an anticholinergic for PD. Pain management is addressed with M-Eslon, an extended-release morphine sulfate, while Yondelis targets soft tissue sarcoma. Beyond these, the portfolio includes Hesperco, an immune-supporting bioflavonoid antioxidant; Ametop, a skin anesthetic used before venous procedures; Ethacrynate Sodium, a loop diuretic for high blood pressure and swelling; and Amikacin, an injectable antibiotic. Founded in 2003, Valeo Pharma Inc. is headquartered in Kirkland, Canada.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$9.87K
Change (1 day)
0.00%
Change (1 year)
-66.67%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Valeo Pharma Inc. (VPHIF)
EPS as of July 2024 TTM: $-0.25
According to Valeo Pharma Inc.'s latest financial reports, its current EPS (TTM) is $-0.25. At the end of 2023 the company had an EPS of $-0.23, an increase over its 2022 EPS of $-0.24.
EPS history for Valeo Pharma Inc. from 2016 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.25 7.09%
2023 $-0.23 -1.87%
2022 $-0.24 45.57%
2021 $-0.16 161.75%
2020 $-0.06 11.37%
2019 $-0.06 45.03%
2018 $-0.04 -34.02%
2017 $-0.06 173.11%
2016 $-0.02 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$6.03 -2,548.19%
DE
$6.01 -2,539.22%
DE
$1.53 -722.37%
JP
$3.66 -1,585.99%
CH
$0.45 -282.70%
IL

Questions about Valeo Pharma Inc.'s earnings per share (EPS)

What is Valeo Pharma Inc.'s earnings per share (EPS)?

Valeo Pharma Inc.'s earnings per share (EPS) over the last twelve months is $-0.25, as of Jul 2024.

What was Valeo Pharma Inc.'s earnings per share (EPS) in 2023?

In 2023, Valeo Pharma Inc.'s earnings per share (EPS) was $-0.23, compared with $-0.24 in 2022.

How has Valeo Pharma Inc.'s earnings per share (EPS) changed since 2018?

From 2018 to 2023, Valeo Pharma Inc.'s earnings per share (EPS) was highest in 2018 ($-0.04) and lowest in 2022 ($-0.24).

How does Valeo Pharma Inc.'s earnings per share (EPS) compare with similar companies?

Valeo Pharma Inc.'s earnings per share (EPS) ($-0.25) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.